Research and development
Atrys has different areas of complementary activity that are closely interrelated, which include the area of translational research.
The main activity of this area is based in collaborations with public research organizations (PROs), referral hospitals, and / or small and medium enterprises (SMEs).
These collaborations support the growth in the portfolio of knowledge of the company, at the same time that are possible thanks to the participation of Atrys entire team, enabling the management and development of diverse active research projects.
Our focus
Atrys has launched diverse R&D projects in collaboration with leading academic and health centers.
In general, our projects focus on the integrated analysis of functional and molecular properties in different human tumor types to define a specific phenotype for each patient, altoghether with the development of models and tools for predicting therapeutic response in oncology that can generate marketable predictive test.
Atrys has been recognized as an innovative SME (Pyme Innovadora) by the Ministry of Economy and Competitiveness. This seal, created for small and medium-sized enterprises (SMEs), officially recognizes the effort of our company to research and innovate in the medical sector.
